Biochemistry, Genetics and Molecular Biology
Electrocardiogram
100%
Phospholamban
100%
Cardiac Dysrhythmia
66%
Electric Potential
55%
Erythropoietin Receptor
50%
Mitochondrial Dynamics
50%
Kinase
50%
Skeletal Muscle
50%
Phosphotransferase
50%
Synapsin I
50%
Population
50%
Atrial Fibrillation
50%
Fat Mass
50%
Energy Metabolism
50%
Mitochondrial Biogenesis
50%
Mitochondrial Protein
50%
Eicosanoid Receptor
50%
Mouse
38%
Exercise
29%
Wild Type Mouse
15%
Cardiac Muscle Cell
14%
Erythropoietin
12%
Mitophagy
10%
T Wave
10%
Proteomics
9%
Electron Microscopy
9%
Oxidative Stress
9%
Mitochondrial Fission
9%
Waist Circumference
8%
Phenotype
6%
Heart Function
6%
Angiogenesis
6%
Erythropoiesis
6%
Genetic Marker
6%
Adaptation
6%
Premature Ventricular Contraction
5%
Proband
5%
Heart Left Ventricle Ejection Fraction
5%
Calcium Homeostasis
5%
Medicine and Dentistry
Phospholamban
100%
Electrocardiogram
100%
Cardiomyopathy
100%
Heart Failure
100%
Heart Ventricle Arrhythmia
66%
Cardiac Magnetic Resonance Imaging
50%
Atrial Fibrillation
50%
Coronary Artery Disease
50%
Population
50%
Cardiac Fibrosis
50%
Galectin 3
50%
Gadolinium
50%
Fibrosis
22%
Cardiovascular Risk
16%
Biological Marker
16%
Cardiovascular Disease
16%
Myocardium
11%
Adverse Event
11%
T1 Contrast
11%
T Wave
10%
Proportional Hazards Model
10%
Diagnosis
10%
Youden Index
8%
Systolic Blood Pressure
8%
Logistic Regression Analysis
8%
Body Fat Percentage
8%
Body Mass Index
8%
Hydroxybutyrate Dehydrogenase
7%
Myocardial Scarring
5%
Heart Left Ventricle Ejection Fraction
5%
All Cause Mortality
5%
Premature Ventricular Contraction
5%
Myocardial Infarction
5%
Adverse Outcome
5%
Calcium Homeostasis
5%
Scar Formation
5%
Outpatient
5%
Cardiac Muscle Cell
5%
Immunohistochemistry
5%
Defibrillator
5%
Risk Stratification
5%
Keyphrases
Heart Failure
54%
EPO Receptor
50%
Erythropoietin Receptor
50%
Mitochondrial Biogenesis
50%
Skeletal muscle
50%
Coronary Artery Disease
50%
Atrial Fibrillation Heart Failure
50%
Cardiac Magnetic Resonance Imaging (cMRI)
50%
Myocardial Fibrosis
50%
Outcome Prediction
50%
Incident Atrial Fibrillation
50%
Galectin-3 (Gal-3)
50%
Relative Fat Mass
50%
Late Gadolinium Enhancement
50%
T1 Time
22%
BDH1
21%
Exercise Performance
18%
Cardiac Biomarkers
16%
Diffuse Fibrosis
16%
Heart Failure Patients
16%
State 3 Respiration
13%
Mitochondrial Content
12%
Cardiac muscle
12%
Hematopoietic Tissue
12%
Post-contrast
11%
Adverse Events
11%
Focal Fibrosis
11%
Intracardiac Defibrillator
10%
Composite Outcome
8%
Obesity Risk
8%
Cardiovascular Risk Prediction
8%
Waist Circumference
8%
Cardiovascular Risk
8%
Pathological Stress
6%
Muscle Type
6%
Erythropoiesis
6%
Exercise-induced
6%
Cardiac Function
6%
Gross Morphology
6%
Left Ventricle
6%
Muscle Physiology
6%
Wild Mice
6%
Physiological Adaptation
6%
Endogenous Erythropoietin
6%
Receptor System
6%
Exercise Capacity
6%
Gastrocnemius
6%
Angiogenesis
6%
Molecular Markers
6%
Voluntary Exercise
6%
